Menu Back to ACCELERATING-ACCESS-TO-INNOVATIVE-PRODUCTS-IMPROVING-RESPONSES-TO-PANDEMIC-DISEASES

Overview

DIA and the Duke-NUS Centre of Regulatory Excellence (CoRE) will host a 2-day conference in Singapore on accelerating access to health products to improve the response to pandemic diseases. Over these 2 days, we will discuss the global impact of infectious diseases and approaches to expedite research and product development (including vaccines and medical devices). We will also explore the pathways to accelerate patient access to innovative products and how to effectively manage a pandemic situation in Asia. Speakers will include experts from Health Authorities, NGOs, as well as the industry and academia.

Download Registration Form

Who should attend?

  • Industry professionals involved in Research & Development, Regulatory Affairs and Medical Affairs in Pharmaceuticals and Medical Technology
  • Regulators and personnel from Health Authorities and Ministries
  • Academia and Researchers

    Program Committee

    • Dorothee  Grimald, PharmD
      Dorothee Grimald, PharmD Director, Global Regulatory Policy
      MSD International GmbH, Singapore
    • James  Leong, PhD, MPharm
      James Leong, PhD, MPharm Head of Education, Centre of Regulatory Excellence, Graduate Medical School
      Duke NUS, Singapore
    • Esther Siu-Suet Chu, MBA
      Esther Siu-Suet Chu, MBA Head/ Executive Director, Drug Development Operations (APAC)
      Allergan Singapore Pte Ltd, Singapore
    • Finny  Liu
      Finny Liu APAC Regional Regulatory Policy Lead,
      PDR, Roche, Singapore , Singapore
    • Michelle  Cheng, RPh, RAC
      Michelle Cheng, RPh, RAC Head of Regulatory Affairs, Singapore & Asian Emerging Markets
      Novartis Singapore Pte Ltd, Singapore
    • Thean Soo  Lo
      Thean Soo Lo Director, Asia Pacific Regulatory Policy Lead, Global Regulatory Affairs
      Janssen-Cilag J&J Asia Pacific, Singapore
    • Silke  Vogel, PhD
      Silke Vogel, PhD Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean
      Duke NUS , Singapore
    • Jin  Shun, MBA
      Jin Shun, MBA Head, Regulatory Affairs, APAC
      Abbott Laboratories (Singapore) Pte. Ltd., Singapore
    • Jing Ping  Yeo, PhD
      Jing Ping Yeo, PhD Director, Research Integrity, Compliance and Ethics
      Singapore Health Services Pte Ltd, Singapore
    • Kum Cheun  Wong, PharmD
      Kum Cheun Wong, PharmD Head Asia Pacific, Regulatory & Development Policy, Regulatory Affairs
      Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
    • Stephanie  Danandjaja
      Stephanie Danandjaja APAC Medical Director
      Abbott EPD, Singapore
    • Vicky (Fengyun)  Han
      Vicky (Fengyun) Han Senior Director, Regulatory Policy Group Lead for Asia Pacific
      Janssen Pharmaceutical Companies of Johnson & Johnson, Singapore
    Load More

    Contact us

    Digital Learning Catalog

    eLearning Catalog Cover
    Download